Palatin Technologies (PTN) Inventory (2020 - 2023)
Palatin Technologies' (PTN) quarterly Inventory came in at $1.6 million in Q3 2023, up 86.28% YoY from $857975.0 in Q3 2022, and up 203.85% on a QoQ basis from $526000.0 in Q2 2023.
Palatin Technologies (PTN) Inventory (2020 - 2023) Analysis & Trends
Palatin Technologies (PTN) has 4 years of Inventory data on file, last reported at $1.6 million in Q3 2023.
- Quarterly Inventory rose 86.28% year-over-year to $1.6 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $1.6 million (up 86.28% YoY) and the FY2023 annual result came in at $526000.0, down 44.31% from the prior year.
- Inventory advanced to $1.6 million in Q3 2023, from $526000.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $6.1 million in Q1 2021 to a low of $526000.0 in Q2 2023.
- A 4-year average of $2.1 million and a median of $1.1 million in 2021 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory slumped 83.12% — and 2023, when it surged 86.28%.
- Tracing PTN's Inventory over 4 years: stood at $6.0 million in 2020, then plunged by 82.11% to $1.1 million in 2021, then fell by 29.63% to $759268.0 in 2022, then jumped by 110.5% to $1.6 million in 2023.
- The last three Inventory figures came in at $1.6 million (Q3 2023), $526000.0 (Q2 2023), and $630033.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 526,000.00 |
| Mar 31, 2023 | 630,033.00 |
| Dec 31, 2022 | 759,268.00 |
| Sep 30, 2022 | 857,975.00 |
| Jun 30, 2022 | 944,471.00 |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 6.11 Mn |
| Dec 31, 2020 | 6.03 Mn |
| Sep 30, 2020 | 5.79 Mn |